Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-056524
Filing Date
2021-09-16
Accepted
2021-09-16 21:26:28
Documents
1
Period of Report
2021-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16648
  Complete submission text file 0001209191-21-056524.txt   18267
Mailing Address C/O GENENTECH INC 1 DNA WAY MS 49 SOUTH SAN FRANCISCO CA 94080-4990
Business Address
SCHELLER RICHARD H (Reporting) CIK: 0001214133 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40794 | Film No.: 211259105

Mailing Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080
Business Address 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Issuer) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations